Atorvastatin Decreases C-Reactive Protein-Induced Inflammatory Response in Pulmonary Artery Smooth Muscle Cells by Inhibiting Nuclear Factor-ÎºB Pathway-Reference-Cited by-同舟云学术

Atorvastatin Decreases C-Reactive Protein-Induced Inflammatory Response in Pulmonary Artery Smooth Muscle Cells by Inhibiting Nuclear Factor-ÎºB Pathway

Published:2010-02 Issue:1 Volume:28 Page:8-14
ISSN:1755-5914
Container-title:Cardiovascular Therapeutics
language:en
Short-container-title:

Author:

Li Jie,Li Jian-Jun,He Jian-Guo,Nan Jing-long,Guo Yuan-lin,Xiong Chang-ming

Publisher

Wiley

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-5922.2009.00103.x/fullpdf

Reference32 articles.

1. Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension;Itoh;Respirology,2006

2. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension;Humbert;Am J Respir Crit Care Med,1995

3. Platelet derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients;Humbert;Eur Respir J,1998

4. Epoprostenol therapy decreases elevated circulating levels of monocyte chemoattractant protein-1 in patients with primary pulmonary hypertension;Katsushi;Circ J,2004

5. C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease;Elstein;Blood Cells Mol Dis,2005

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin-6 and pulmonary hypertension: from physiopathology to therapy;Frontiers in Immunology;2023-06-28

2. The Cellular and Molecular Mechanisms of Ovarian Aging;Ovarian Aging;2023

3. Statin contribution to middle cerebral artery blood flow velocity in older adults at risk for dementia;European Journal of Applied Physiology;2022-08-12

4. An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers;Frontiers in Cardiovascular Medicine;2022-07-14

5. Reply to Letter to the Editor: C-reactive protein and cardiovascular events in obstructive and nonobstructive coronary artery disease;Cardiology Plus;2022-04